New Innovations for Cardiovascular Diseases

Open TechNotes here:
Markers of Cardiovascular Diseases Catalog.

Cardiovascular diseases (CVD) are the most lethal diseases in the Western world. As the standard of living is growing, CVD are going to be the leading cause of mortality in the whole world in the near future. This means more demanding challenges to scientifi c communities to research and develop new and more specifi c diagnostic approaches to unstable angina, acute myocardial infarction (AMI) and other life threatening cardiovascular pathologies. In this fi eld, different cardiac markers have already today a major role, but the demand for more effective and sensitive cardiac markers that could be used not only for the diagnosis but also for the prognosis of different cardiac pathologies is widely recognized in the whole clinical world.

For more than 15 years, HyTest specialists have been involved in the development and production of high quality products applicable for research and in vitro diagnostic activities (IVD) in the cardiovascular fi eld. Today, we can proudly say that HyTest is the leading producer of different reagents for cardiac diagnostics. Our reagents are widely used for the development of sensitive and precise immunoassays, some of our cardiac protein preparations were selected as international standards. We are constantly widening the product range and encouraging contacts with our customers.

There is one feature distinguishing HyTest products from the similar products of other companies. The majority of antibodies described in this catalogue were tested not only with purifi ed antigen, but also with the antigen that could be found in human blood, urine and different tissues. For the development of Introduction sandwich immunoassays, we are recommending selected pairs of antibodies. Our task is to minimize customers’ efforts and time spent for the development of immunoassays. We are offering products that could be used by our customers without additional research work.